Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT03675360 Completed - Diabetes Clinical Trials

Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial

ADEPT
Start date: September 25, 2018
Phase: N/A
Study type: Interventional

The proposed randomized controlled trial will test the effect of a low-carbohydrate diet on hemoglobin A1c among individuals with elevated hemoglobin A1c that are within the range of prediabetes or diabetes. Results may provide evidence about the role of carbohydrate restriction in individuals with or at high risk of type 2 diabetes.

NCT ID: NCT03671161 Completed - Clinical trials for Diabetes Mellitus, Type 1

Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients

FREESTYLE
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Patients with diabetes type 1 with poor glycemic control will be switched to insulin pump and FGM system (Flash Glucose Monitoring) during 6 months, correlated to the hypothesis that they could benefit from this intervention by being reengaged in diabetes self-management.

NCT ID: NCT03665636 Completed - Clinical trials for Glycogen Storage Disease Type I

Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I

Start date: October 16, 2020
Phase: Early Phase 1
Study type: Interventional

This study will be an open-label, prospective, interventional feasibility pilot project to study the efficacy, safety, and tolerability of UX007 (triheptanoin) on reducing hypoglycemic events in patients with GSD I. Subjects will serve as their own control. Five (5) subjects who are treatment naïve to UX007 (triheptanoin) and are already on standard dietary therapy for GSDI will be enrolled. The primary objective is to evaluate the efficacy, safety, and tolerability of UX007 (triheptanoin) in patients with GSD I. The secondary objectives include evaluating the effect of UX007 (triheptanoin) on maintaining the duration of normoglycemia between meals based on glucose monitoring (Preventing and reducing the frequency of hypoglycemia); reduction/stabilization of the dose of cornstarch; and the prevention of increased liver steatosis based on ultrasound with elastography.

NCT ID: NCT03623139 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to examine the health benefits of adding a concept in basic carbohydrate counting (BCC) to the routine outpatient nutritional education for adult patients with type 2 diabetes. The study hypothesis is that training and education in the BCC concept will improve glycaemic control either by reducing HbA1c or the average plasma glucose variability more than offering the routine dietary care as a stand-alone dietary treatment.

NCT ID: NCT03623113 Completed - Type1diabetes Clinical Trials

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The study is designed to evaluate two different dietitian-led self-management approaches in carbohydrate counting compared to routine dietary care (control) on glycaemic control in adult patients with type 1 diabetes: 1. The basic carbohydrate counting concept aims at improving carbohydrate counting accuracy and day-to-day consistency of carbohydrate intake (the BCC intervention) 2. The advanced carbohydrate counting concept aims at improving prandial insulin dose accuracy using an automated bolus calculator (the ABC-ACC intervention) The main hypothesis is that structured training and education in either the BCC concept or the ABC-ACC concept will reduce HbA1c or the average glucose variability more than routine dietary education.

NCT ID: NCT03620071 Completed - Cerebral Palsy Clinical Trials

GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity

GoalKeeper
Start date: April 19, 2019
Phase: N/A
Study type: Interventional

This proposal addresses the major challenge of improving health outcomes for children with cancer and other complex conditions, for whom the effectiveness of outpatient care depends on care coordination across a diverse group of caregivers that includes parents, community support organizations and pediatric care providers. The investigators have developed GoalKeeper, a prototype system for supporting care coordination across multiple care providers. The primary aim of the clinical trial is to assess the potential for this new system, GoalKeeper, to improve meaningful use of goal-centered care plans in the care of children with cancer and other complex chronic conditions.

NCT ID: NCT03610087 Completed - Clinical trials for Cardiovascular Risk Factor

Technology-Enabled Collaborative Care for Youth

TECC-Y
Start date: July 25, 2018
Phase: N/A
Study type: Interventional

The overall objective is to develop scalable interventions to address the physical health needs of patients affected by early psychosis. The objective of this project is to conduct a feasibility study of a high intensity technology-enabled collaborative care model (CCM) compared to lower intensity self-help modules and email support for early identification and treatment of cardio-metabolic risk factors in youth, ages 16-29, affected by early psychosis.

NCT ID: NCT03594812 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Aerobic Exercise Associated With Abdominal Radiofrequency on on Adipose Tissue in Women:

Start date: July 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the present study was to evaluate the effects of one session of aerobic exercise associated with radiofrequency in lipolytic activity and lipid profile.

NCT ID: NCT03582826 Completed - Clinical trials for Nutritional and Metabolic Diseases

Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions

PATM
Start date: June 16, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to identify microbial signatures associated with remission and recurrence of idiopathic malodor and PATM conditions.

NCT ID: NCT03557541 Completed - Clinical trials for Diabetes Mellitus, Type 2

Sardine-enriched Diet for Prevention Type 2 Diabetes

Start date: May 2014
Phase: N/A
Study type: Interventional

The hypothesis formulated is that 200 g of sardine on a weekly basis will have a favourable impact avoiding the natural development of the pathology due to changes in the biochemical profile, the anthropometrics, inflammatory markers, changes in gut microbiota populations, also in transcriptomics and metabolomics.